Who Paid My Doc
Eric Strauss
Surgery of the Hand Voorhees, NJ Medical Doctor
NPI 1912093428 CMS profile 417718
200 Bowman Dr Ste E140, Voorhees, NJ 08043
General payments
$8,980
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Eric Strauss of Voorhees, NJ is reported in the CMS Open Payments database as having received $8,980 across 43 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 82nd percentile of Surgery of the Hand profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $17 | 1 | |
| 2024 | General | $1,122 | 2 | |
| 2023 | General | $45 | 3 | |
| 2022 | General | $2,758 | 10 | |
| 2021 | General | $2,992 | 11 | |
| 2020 | General | $157 | 2 | |
| 2019 | General | $1,888 | 14 |
Beside peers
- Eric Strauss
- Surgery of the Hand median
- Middle half of Surgery of the Hand
- National median
In program year 2025, general payments to Eric Strauss were reported at $17. Among 286 Surgery of the Hand profiles paid that year, the median was $288 and the middle half received between $115 and $1,242.
Show as a table
| Year | Eric Strauss | Surgery of the Hand median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,888 | $369 | $108–$1,516 | $163 |
| 2020 | $157 | $153 | $56–$898 | $114 |
| 2021 | $2,992 | $261 | $84–$1,296 | $132 |
| 2022 | $2,758 | $313 | $103–$1,562 | $149 |
| 2023 | $45 | $241 | $95–$876 | $160 |
| 2024 | $1,122 | $236 | $84–$890 | $164 |
| 2025 | $17 | $288 | $115–$1,242 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 84 billing codesPaid by Medicare
$174,079
Medicare patients
358
Services billed
1,427
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 65% | |
| Diabetes | 35% | |
| Ischemic heart disease | 31% | |
| Chronic kidney disease | 19% | |
| Cancer | 19% | |
| Depression | 19% | |
| Atrial fibrillation | 18% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 | Office | 143 | 308 | $232 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
43 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Surgery of the Hand in New Jersey
Related records
Surgery of the Hand in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Surgery of the Hand
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.